Top Markets
Coin of the day
BioLineRx Ltd. BioLineRx Ltd.

BioLineRx Ltd.

BLRX
Rang in aandelen #40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Aandeelprijs
$0.0048574
Marktkapitalisatie
$126.82K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-21.82%
Land
IL
Handel BioLineRx Ltd. (BLRX)

Categorie

Dividendrendementgeschiedenis voor BioLineRx Ltd. (BLRX)
Het dividendrendement (TTM) van BioLineRx Ltd. (aandelsymbool: BLRX) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van BioLineRx Ltd. (BLRX) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten